SynthesisInternational journal of obesity (2005)2026
High body mass index within the normal weight range and risk of type 2 diabetes and hypertension in US and Europe: a systematic review and meta-analysis.
Synthesis in International journal of obesity (2005), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND/
objectiveClinical guidelines suggest body mass index (BMI) thresholds of ≥25 kg/m² to identify individuals at elevated risk of type 2 diabetes and (T2D) hypertension, however, growing evidence suggests that higher BMI values within the normal weight range may also be associated with increased risks.
methodsA systematic search was conducted in PubMed and Scopus, with an updated PubMed search through October 2025, to identify cohort studies from the US and Europe that reported risk estimates of T2D or hypertension for higher normal weight BMI values (e.g., 22.5-24.9 kg/m²) compared with lower normal weight BMI values. Asian studies were excluded because of lower BMI thresholds in Asian populations. Random-effects meta-analysis was performed to estimate summary relative risks (RRs) and 95%CIs.
resultsEleven cohort studies were included, with 23% of participants and 17% of cases being classified as having high normal weight BMI values (22.5-24.9 kg/m²). Compared with lower BMI values within the normal weight range, high normal weight BMI values were associated with a greater risk of T2D (RR = 1.78, 95% CI: 1.30-2.45, I² = 98%; n = 10 studies with 1,818,036 participants and 84,414 cases; moderate certainty evidence). Evidence for hypertension was limited, based on three US cohort studies (RR = 1.42, 95% CI: 1.33-1.51, I
conclusionsCompared with lower normal weight BMI values, higher BMI within the normal range was associated with a higher risk of T2D and hypertension, suggesting that current BMI classifications may not fully capture the increased risk among individuals at the upper end of the normal weight spectrum. If replicated, the findings may justify reconsideration of BMI thresholds to better reflect the higher cardiometabolic risk observed among individuals with high normal weight BMI.
Identifiers
42587020What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.